Investigating proteasome inhibitors as potential adjunct therapies for experimental cerebral malaria

E-ISSN： 1365-3024|37|11|599-604

ISSN： 0141-9838

Source： PARASITE IMMUNOLOGY (ELECTRONIC), Vol.37, Iss.11, 2015-11, pp. : 599-604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Totally drug‐resistant tuberculosis and adjunct therapies

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 4, 2015-04 ,pp. : 388-405

John Wiley & Sons Inc

Access to resources Recommend Favorite

Critical role of IL‐33 receptor ST2 in experimental cerebral malaria development

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 5, 2015-05 ,pp. : 1354-1365

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complement C5‐deficient mice are protected from seizures in experimental cerebral malaria

EPILEPSIA, Vol. 55, Iss. 12, 2014-12 ,pp. : e139-e142

John Wiley & Sons Inc

Access to resources Recommend Favorite

Retinal changes in adults with cerebral malaria

By Beare N. A. V. Lewis D. K. Kublin J. G. Harding S. P. Zijlstra E. E. Molyneux M. E.

Annals of Tropical Medicine and Parasitology, Vol. 97, Iss. 3, 2003-04 ,pp. : 313-315

Maney Publishing

Access to resources Recommend Favorite

Cerebral malaria: clinical pathophysiology and treatment features,

By Warrell D. A.

Annals of Tropical Medicine and Parasitology, Vol. 91, Iss. 7, 1997-10 ,pp. : 875-884

Routledge Ltd

Access to resources Recommend Favorite